معرفی
Ji Liu, MD, MS is an Associate Professor on Term in the Department of Ophthalmology and Visual Science at Yale School of Medicine. He joined Yale Eye Center as Assistant Professor in July 2013 and was later promoted to Associate Professor. Dr. Liu serves as Director for Resident Research in Ophthalmology and is dedicated to patient care, medical education, and research in ophthalmology.
- Education: MD from Hunan Medical University (1997), MS from Xiangya School of Medicine (2000)
- Residency: George Washington University Medical Center (2012)
- Fellowship: Yale Eye Center (Clinical Glaucoma Fellow)
- Research Experience: Scheie Eye Institute, University of Pennsylvania
Dr. Liu's research focuses on intraocular pressure monitoring, medical and surgical management of glaucoma, ophthalmic laser, cataract surgery, premium intraocular lens implant, and complex anterior segment surgeries. His work demonstrates a strong commitment to advancing treatments for eye diseases while improving patient outcomes. He has introduced multiple novel glaucoma surgeries to Yale-New Haven Hospital, including I-stent, I-track, and Xen Gel Stent.
His publication record shows consistent contributions to ophthalmology literature, with recent articles spanning gene therapy, ocular development, pain management protocols, corticosteroid-induced glaucoma, and surgical trends. The research demonstrates expertise across clinical ophthalmology, surgical innovation, and medical education.
- M. Bruce Shields Award for Excellence in Teaching by Full Time Faculty (2020)
- M. Bruce Shields Award for Excellence in Teaching by Full Time Faculty (2015)
- Connecticut Magazine's Top Doctor (2022)
- 2004 Annual Research Award at Scheie Eye Institute
Dr. Liu works closely with medical students, residents, and fellows, demonstrating strong commitment to medical education. He has been recognized with the prestigious Bruce Shields Award for Excellence in Teaching twice. His clinical work involves complex lens, iris, and glaucoma surgeries with a focus on restoring vision and stopping glaucoma progression. He is actively involved with professional organizations including the World Glaucoma Association (2013-present) and American Academy of Ophthalmology (2014-present), and has served as a reviewer for multiple ophthalmology journals.
